1. Home
  2. ENZ vs CGTX Comparison

ENZ vs CGTX Comparison

Compare ENZ & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENZ
  • CGTX
  • Stock Information
  • Founded
  • ENZ 1976
  • CGTX 2007
  • Country
  • ENZ United States
  • CGTX United States
  • Employees
  • ENZ N/A
  • CGTX N/A
  • Industry
  • ENZ Medical Specialities
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ENZ Health Care
  • CGTX Health Care
  • Exchange
  • ENZ Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • ENZ 34.2M
  • CGTX 30.0M
  • IPO Year
  • ENZ N/A
  • CGTX 2021
  • Fundamental
  • Price
  • ENZ $0.55
  • CGTX $0.59
  • Analyst Decision
  • ENZ
  • CGTX Strong Buy
  • Analyst Count
  • ENZ 0
  • CGTX 6
  • Target Price
  • ENZ N/A
  • CGTX $8.30
  • AVG Volume (30 Days)
  • ENZ 167.5K
  • CGTX 821.4K
  • Earning Date
  • ENZ 03-12-2025
  • CGTX 03-25-2025
  • Dividend Yield
  • ENZ N/A
  • CGTX N/A
  • EPS Growth
  • ENZ N/A
  • CGTX N/A
  • EPS
  • ENZ N/A
  • CGTX N/A
  • Revenue
  • ENZ $30,314,000.00
  • CGTX N/A
  • Revenue This Year
  • ENZ N/A
  • CGTX N/A
  • Revenue Next Year
  • ENZ N/A
  • CGTX N/A
  • P/E Ratio
  • ENZ N/A
  • CGTX N/A
  • Revenue Growth
  • ENZ N/A
  • CGTX N/A
  • 52 Week Low
  • ENZ $0.41
  • CGTX $0.34
  • 52 Week High
  • ENZ $1.40
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • ENZ 36.19
  • CGTX 39.91
  • Support Level
  • ENZ $0.41
  • CGTX $0.57
  • Resistance Level
  • ENZ $0.69
  • CGTX $0.68
  • Average True Range (ATR)
  • ENZ 0.05
  • CGTX 0.06
  • MACD
  • ENZ 0.00
  • CGTX -0.02
  • Stochastic Oscillator
  • ENZ 54.04
  • CGTX 7.83

About ENZ Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: